Antioxidant therapy for chronic hepatitis C after failure of interferon: Results of phase II randomized, double-blind placebo controlled clinical trial

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 40

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

279

HTML

2093

Figures (1-4)

209

Sum=2581

Oct 28, 2007 (publication date) through Dec 1, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Oct 28, 2007; 13(40): 5317-5323
Published online Oct 28, 2007. doi: 10.3748/wjg.v13.i40.5317

Full Size Figure Download Figure

Figure 2 Proportions of patients with improvement in ALT (A) and AST (B).

Citation: Gabbay E, Zigmond E, Pappo O, Hemed N, Rowe M, Zabrecky G, Cohen R, Ilan Y. Antioxidant therapy for chronic hepatitis C after failure of interferon: Results of phase II randomized, double-blind placebo controlled clinical trial. World J Gastroenterol 2007; 13(40): 5317-5323
URL: https://www.wjgnet.com/1007-9327/full/v13/i40/5317.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i40.5317